Inogen, Inc. (INGN) |
| 6.42 0.24 (3.88%) 10-12 16:00 |
| Open: | 6.155 |
| High: | 6.45 |
| Low: | 6.155 |
| Volume: | 236,921 |
| Market Cap: | 174(M) |
| PE Ratio: | -7.05 |
| Exchange: | NASDAQ Global Select |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 7.53 |
| Resistance 1: | 6.45 |
| Pivot price: | 5.67 |
| Support 1: | 5.58 |
| Support 2: | 5.05 |
| 52w High: | 9.13 |
| 52w Low: | 5.045 |
Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patients. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.
| EPS | -0.920 |
| Book Value | 6.540 |
| PEG Ratio | 0.00 |
| Gross Profit | 5.942 |
| Profit Margin (%) | -6.94 |
| Operating Margin (%) | -5.13 |
| Return on Assets (ttm) | -5.8 |
| Return on Equity (ttm) | -13.1 |
Thu, 08 Oct 2026
Inogen Inc (INGN) Ticks Up to $5.82 as Shares Hold Above Key Support - Low Risk Entry Stocks - https://www.dars.gov.et/
Thu, 01 Oct 2026
Inogen: Selling Rental Is A Start, Continued Work To Be Done (NASDAQ:INGN) - Seeking Alpha
Wed, 30 Sep 2026
Inogen to Sell U.S. Oxygen Rental Assets to Rotech Healthcare for Up to $24.8 Million - TradingView
Wed, 30 Sep 2026
Inogen Announces Divestiture of Its U.S. Oxygen Rental Business to Rotech - Business Wire
Tue, 11 Aug 2026
Should Investors Buy Inogen as Low Valuation Meets Execution Risk? - TradingView
Sun, 09 Aug 2026
Inogen, Inc. (NASDAQ:INGN) Released Earnings Last Week And Analysts Lifted Their Price Target To US$12.67 - Simply Wall Street
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |